Tuesday, September 08, 2020
Both multinational and domestic Contract Development and Manufacturing Organizations (CDMOs) are striving to enter this new segment in China. The recent regulatory reforms, and the potential opportunities are creating an upswell in investment and ...
Recent growth in the biopharmaceutical industry in both China, and India suggest a future positive outlook for contract manufacturing in both regions.